Private equity firm CVC seeks to cash in on the Covid fight

Private equity firm CVC seeks to cash in on the Covid fight by investing in firms running the vaccine rollout

CVC Capital Partners has reportedly snapped up stake in firms involved in running the computer system  behind Covid-19 jabs

A private equity firm has sought to cash in on the coronavirus vaccine rollout by investing in businesses underpinning the effort.

CVC Capital Partners has reportedly snapped up a majority stake in Kent-based System C, and a minority stake in Milton Keynes-based Graphnet Health from US rival Symphony Technology.

The two healthcare technology firms are involved in running the computer system powering the rollout of Covid-19 jabs.

System C and Graphnet were valued at less than £500million combined under the deal, according to the Financial Times. But Luxembourg-based CVC is hoping that their values will soon rocket.

System C employs more than 500 people and provides digital health records services to the NHS.

Graphnet provides software for record-keeping, care planning and data analysis.